
Nasal Drug Delivery Technology Market Report 2023-2033
Description
Nasal Drug Delivery Technology Market Report 2023-2033
The Nasal Drug Delivery Technology Market Report 2022-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increasing Demand for Alternative Drug Delivery Methods Coupled with Advancements In Product Development Driving Market Growth
Some of the major forces propelling the nasal drug delivery technology market include surge in demand for better drug delivery methods, and advancements in product packing and development. Furthermore, rising prevalence of allergic rhinitis and increasing cases of asthma are expected to propel market growth. On the other hand, rise in adoption of generic nasal delivery drugs coupled with new launches are expected to further boost market growth. Developing a successful nasal drug product requires expertise in a variety of areas, including formulation development, device design, clinical trial design, regulatory compliance, and commercialization. Market players are entering into strategic partnerships such as agreement and mergers to meet the growing market demand for effective nasal drugs. Many pharmaceutical companies developing a nasal drug product are partnering with a device manufacturer to design and manufacture a nasal delivery device that is optimized for the specific drug formulation.
On the other hand, production of pharmaceutical products is subject to strict consumer safety regulations. Before a product is finally marketed, lengthy and laborious processes are typically required for medical device and medicine approvals. Companies who engage in significant R&D to introduce new items to the market typically find this to be a hurdle. These stringent regulations are anticipated to hinder the growth of this market over the forecast period.
Complications with Nasal Drug Overuse Likely to Challenge Market Growth
Overuse of nasal drugs can lead to a variety of side effects, some of which can be serious. Rebound congestion, nosebleed, and irritation of nasal membrane are some of the side effects of nasal spray overuse. Many people mistakenly believe that nasal sprays are safe to use since they are widely accessible as over-the-counter medications, and they are ignorant of the potential side effects and addiction linked to them. Regular nasal spray users are prone to developing a habit of abusing the medicine. When their symptoms get worse, people take the prescription more frequently, which frequently results in rhinitis medicamentosa, a disorder. This frequently leads to a condition known as septal perforation—a hole in the inner wall of the nose—in situations of misuse.
What Questions Should You Ask before Buying a Market Research Report?
Forecasts to 2033 and other analyses reveal commercial prospects
Segments Covered in the Report
Container
- Nasal Congestion
- Asthma
- Others
- Cardiovascular Disorders
- Neuropsychiatry
- Others
End-users
North America
Leading companies and the potential for market growth
How will the Nasal Drug Delivery Technology Market, 2023 to 2033 report help you?
In summary, our 397-page report provides you with the following knowledge:
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Nasal Drug Delivery Technology Market, 2023 to 2033, market-leading companies. You will find data, trends, and predictions.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..
The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.
The Nasal Drug Delivery Technology Market Report 2022-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increasing Demand for Alternative Drug Delivery Methods Coupled with Advancements In Product Development Driving Market Growth
Some of the major forces propelling the nasal drug delivery technology market include surge in demand for better drug delivery methods, and advancements in product packing and development. Furthermore, rising prevalence of allergic rhinitis and increasing cases of asthma are expected to propel market growth. On the other hand, rise in adoption of generic nasal delivery drugs coupled with new launches are expected to further boost market growth. Developing a successful nasal drug product requires expertise in a variety of areas, including formulation development, device design, clinical trial design, regulatory compliance, and commercialization. Market players are entering into strategic partnerships such as agreement and mergers to meet the growing market demand for effective nasal drugs. Many pharmaceutical companies developing a nasal drug product are partnering with a device manufacturer to design and manufacture a nasal delivery device that is optimized for the specific drug formulation.
On the other hand, production of pharmaceutical products is subject to strict consumer safety regulations. Before a product is finally marketed, lengthy and laborious processes are typically required for medical device and medicine approvals. Companies who engage in significant R&D to introduce new items to the market typically find this to be a hurdle. These stringent regulations are anticipated to hinder the growth of this market over the forecast period.
Complications with Nasal Drug Overuse Likely to Challenge Market Growth
Overuse of nasal drugs can lead to a variety of side effects, some of which can be serious. Rebound congestion, nosebleed, and irritation of nasal membrane are some of the side effects of nasal spray overuse. Many people mistakenly believe that nasal sprays are safe to use since they are widely accessible as over-the-counter medications, and they are ignorant of the potential side effects and addiction linked to them. Regular nasal spray users are prone to developing a habit of abusing the medicine. When their symptoms get worse, people take the prescription more frequently, which frequently results in rhinitis medicamentosa, a disorder. This frequently leads to a condition known as septal perforation—a hole in the inner wall of the nose—in situations of misuse.
What Questions Should You Ask before Buying a Market Research Report?
- How is the Nasal Drug Delivery Technology Market evolving?
- What is driving and restraining the nasal drug delivery technology market?
- How will each nasal drug delivery technology submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each nasal drug delivery technology submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading nasal drug delivery technology markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the nasal drug delivery technology projects for these leading companies?
- How will the industry evolve during the period between 2022 and 2033? What are the implications of nasal drug delivery technology projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the nasal drug delivery technology market?
- Where is the nasal drug delivery technology market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
- Our 397-page report provides 141 tables and 251 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them – NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising nasal drug delivery technology prices and recent developments.
Segments Covered in the Report
Container
- Pressurized Containers
- Non-pressurized Containers
- Nasal Bi Dose
- Nasal Multi Dose
- Nasal Unidose
- Nasal Spray
- Nasal Drops and Liquids
- Nasal Gels
- Nasal Powder
- Others
- Respiratory Diseases
- Nasal Congestion
- Asthma
- Others
- Non-respiratory Diseases
- Cardiovascular Disorders
- Neuropsychiatry
- Others
End-users
- Home Health Care
- Hospitals
- Specialty Clinics
- Vaccination Centres
- Ambulatory Surgical Centres
- Others
North America
- U.S.
- Canada
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Switzerland
- Rest of Europe
- Japan
- China
- India
- Australia
- South Korea
- Singapore
- Thailand
- Rest of Asia Pacific
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Rest of Latin America
- GCC
- South Africa
- Turkey
- Egypt
- Rest of MEA
Leading companies and the potential for market growth
- AptarGroup, Inc
- AstraZeneca PLC
- Bayer AG
- Becton, Dickinson, and Company
- Dr. Reddy's Laboratories Ltd.
- Flo Nasal Solution
- GlaxoSmithKline PLC
- H&T Presspart
- Johnson & Johnson
- Merck & Co., Inc.
- Naveh Pharma Ltd
- Nemera
- Novartis AG
- Neurelis Inc.
- OptiNose, Inc.
- Pfizer Inc.
- PendoPharm Inc.
- Recipharm AB
- Teleflex, Inc.
- Teva Pharmaceutical Industries Ltd.
How will the Nasal Drug Delivery Technology Market, 2023 to 2033 report help you?
In summary, our 397-page report provides you with the following knowledge:
- Revenue forecasts to 2033 for Nasal Drug Delivery Technology Market, 2023 to 2033 Market, with forecasts for containers, system, dosage form, application, end user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 30 key national markets – See forecasts for the Nasal Drug Delivery Technology Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Nasal Drug Delivery Technology Market, 2023 to 2033.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Nasal Drug Delivery Technology Market, 2023 to 2033, market-leading companies. You will find data, trends, and predictions.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..
The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.
Table of Contents
397 Pages
- 1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Nasal drug delivery technology market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report
- 1.6 Who is This Report for?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Reports
- 1.10 About
- 2 Executive Summary
- 3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.2.1 Market Driving Factors
- 3.2.1.1 High Prevalence of Allergic Rhinitis to Spur Demand
- 3.2.1.2 Multiple Benefits Associated with Multi-dose Nasal Spray Packaging to Boost Industry Growth
- 3.2.1.3 Chronic Respiratory Diseases Driving Market Growth
- 3.2.1.4 Need for Generic Inhalation and Nasal Spray Drugs to Boost Industry Growth
- 3.2.1.5 Support from Government and NGOs for Respiratory Diseases Healthcare Awareness to Spur Market Growth
- 3.2.1.6 Advanced Inhalation Methods to Augment Market Growth
- 3.2.2 Market Restraining Factors
- 3.2.2.1 Product Development Regulations Likely to Restrain Market Growth
- 3.2.2.2 Complications Associated with the Overuse of Nasal Sprays
- 3.2.3 Market Opportunities
- 3.2.3.1 Emerging Opportunities for Nasal Devices
- 3.2.3.2 Nasal Drug Delivery Has Evolved into a Highly Versatile Method of Administration for Locally Acting And Systemic Drugs
- 3.2.3.3 Rising Demand for Generic Drugs is Expected to Enhance Market Growth
- 3.2.3.4 DPI Technology Driving the Adoption of Nasal Drugs
- 3.3 COVID-19 Impact Analysis
- 3.4 Porter’s Five Forces Analysis
- 3.4.1 Bargaining Power of Suppliers
- 3.4.2 Bargaining Power of Buyers
- 3.4.3 Competitive Rivalry
- 3.4.4 Threat from Substitutes
- 3.4.5 Threat of New Entrants
- 3.5 PEST Analysis
- 4 Nasal Drug Delivery Technology Market Analysis by Containers
- 4.1 Key Findings
- 4.2 Container Segment: Market Attractiveness Index
- 4.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
- 4.4 Pressurized Containers
- 4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 4.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.5 Non-pressurized Containers
- 4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
- 4.5.2 Market Share by Region, 2023 & 2033 (%)
- 5 Nasal Drug Delivery Technology Market Analysis by System
- 5.1 Key Findings
- 5.2 System Segment: Market Attractiveness Index
- 5.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
- 5.4 Nasal Bi Dose
- 5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 5.4.2 Market Share by Region, 2023 & 2033 (%)
- 5.5 Nasal Multi Dose
- 5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
- 5.5.2 Market Share by Region, 2023 & 2033 (%)
- 5.6 Nasal Unidose
- 5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
- 5.6.2 Market Share by Region, 2023 & 2033 (%)
- 6 Nasal Drug Delivery Technology Market Analysis By Dosage Form
- 6.1 Key Findings
- 6.2 Dosage Form Segment: Market Attractiveness Index
- 6.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
- 6.4 Nasal Spray
- 6.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 6.4.2 Market Share by Region, 2023 & 2033 (%)
- 6.5 Nasal Drops and Liquid
- 6.5.1 Market Size by Region, 2023-2033 (US$ Billion)
- 6.5.2 Market Share by Region, 2023 & 2033 (%)
- 6.6 Nasal Gels
- 6.6.1 Market Size by Region, 2023-2033 (US$ Billion)
- 6.6.2 Market Share by Region, 2023 & 2033 (%)
- 6.7 Nasal Powder
- 6.7.1 Market Size by Region, 2023-2033 (US$ Billion)
- 6.7.2 Market Share by Region, 2023 & 2033 (%)
- 6.8 Others
- 6.8.1 Market Size by Region, 2023-2033 (US$ Billion)
- 6.8.2 Market Share by Region, 2023 & 2033 (%)
- 7 Nasal Drug Delivery Technology Market Analysis by Application
- 7.1 Key Findings
- 7.2 Application Segment: Market Attractiveness Index
- 7.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
- 7.4 Respiratory Diseases
- 7.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.4.2 Market Share by Region, 2023 & 2033 (%)
- 7.4.3 Allergic Rhinitis
- 7.4.3.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.4.3.2 Market Share by Region, 2023 & 2033 (%)
- 7.4.4 Nasal Congestion
- 7.4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.4.4.2 Market Share by Region, 2023 & 2033 (%)
- 7.4.5 Asthma
- 7.4.5.1 FDA Approved First Generic of Symbicort to Treat Asthma and COPD
- 7.4.5.2 Market Size by Region, 2023-2033 (US$ Billion)
- 7.4.5.3 Market Share by Region, 2023 & 2033 (%)
- 7.4.6 Others
- 7.4.6.1 COPD
- 7.4.6.2 Lupin Launched Nasal Drug For Breathing Problems In United States
- 7.4.6.3 Covid 19
- 7.4.6.4 Market Size by Region, 2023-2033 (US$ Billion)
- 7.4.6.5 Market Share by Region, 2023 & 2033 (%)
- 7.5 Non-respiratory Diseases
- 7.5.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.5.2 Market Share by Region, 2023 & 2033 (%)
- 7.5.3 Alzheimer’s
- 7.5.3.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.5.3.2 Market Share by Region, 2023 & 2033 (%)
- 7.5.4 Cardiovascular Disorders
- 7.5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.5.4.2 Market Share by Region, 2023 & 2033 (%)
- 7.5.5 Neuropsychiatry
- 7.5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.5.5.2 Market Share by Region, 2023 & 2033 (%)
- 7.5.6 Others
- 7.5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.5.6.2 Market Share by Region, 2023 & 2033 (%)
- 8 Nasal Drug Delivery Technology Market Analysis by End-users
- 8.1 Key Findings
- 8.2 End-users Segment: Market Attractiveness Index
- 8.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
- 8.4 Home Health Care
- 8.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 8.4.2 Market Share by Region, 2023 & 2033 (%)
- 8.5 Hospitals
- 8.5.1 Market Size by Region, 2023-2033 (US$ Billion)
- 8.5.2 Market Share by Region, 2023 & 2033 (%)
- 8.6 Speciality Clinics
- 8.6.1 Market Size by Region, 2023-2033 (US$ Billion)
- 8.6.2 Market Share by Region, 2023 & 2033 (%)
- 8.7 Vaccination Centres
- 8.7.1 Market Size by Region, 2023-2033 (US$ Billion)
- 8.7.2 Market Share by Region, 2023 & 2033 (%)
- 8.8 Ambulatory Surgical Centres
- 8.8.1 Market Size by Region, 2023-2033 (US$ Billion)
- 8.8.2 Market Share by Region, 2023 & 2033 (%)
- 8.9 Others
- 8.9.1 Market Size by Region, 2023-2033 (US$ Billion)
- 8.9.2 Market Share by Region, 2023 & 2033 (%)
- 9 Nasal Drug Delivery Technology Market Analysis by Region
- 9.1 Key Findings
- 9.2 Regional Market Size Estimation and Forecast
- 10 North America Nasal Drug Delivery Technology Market Analysis
- 10.1 Key Findings
- 10.2 North America Nasal Drug Delivery Technology Market Attractiveness Index
- 10.3 North America Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
- 10.4 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
- 10.5 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
- 10.6 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
- 10.7 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
- 10.8 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
- 10.9 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
- 10.10 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
- 10.11 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
- 10.12 U.S. Nasal Drug Delivery Technology Market Analysis
- 10.13 Canada Nasal Drug Delivery Technology Market Analysis
- 11 European Nasal Drug Delivery Technology Market Analysis
- 11.1 Key Findings
- 11.2 European Nasal Drug Delivery Technology Market Attractiveness Index
- 11.3 European Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
- 11.4 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
- 11.5 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
- 11.6 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
- 11.7 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
- 11.8 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
- 11.9 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
- 11.10 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
- 11.11 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
- 11.12 Germany Nasal Drug Delivery Technology Market Analysis
- 11.13 UK Nasal Drug Delivery Technology Market Analysis
- 11.14 France Nasal Drug Delivery Technology Market Analysis
- 11.15 Italy Nasal Drug Delivery Technology Market Analysis
- 11.16 Spain Nasal Drug Delivery Technology Market Analysis
- 11.17 Russia Nasal Drug Delivery Technology Market Analysis
- 11.18 Netherlands Nasal Drug Delivery Technology Market Analysis
- 11.19 Switzerland Nasal Drug Delivery Technology Market Analysis
- 11.20 Rest of Europe Nasal Drug Delivery Technology Market Analysis
- 12 Asia Nasal Drug Delivery Technology Market Analysis
- 12.1 Key Findings
- 12.2 Asia Nasal Drug Delivery Technology Market Attractiveness Index
- 12.3 Asia Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
- 12.4 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
- 12.5 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
- 12.6 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
- 12.7 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
- 12.8 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
- 12.9 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
- 12.10 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
- 12.11 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
- 12.12 Japan Nasal Drug Delivery Technology Market Analysis
- 12.13 China Nasal Drug Delivery Technology Market Analysis
- 12.14 India Nasal Drug Delivery Technology Market Analysis
- 12.15 Australia Nasal Drug Delivery Technology Market Analysis
- 12.16 South Korea Nasal Drug Delivery Technology Market Analysis
- 12.17 Singapore Nasal Drug Delivery Technology Market Analysis
- 12.18 Thailand Nasal Drug Delivery Technology Market Analysis
- 12.19 Rest of Asia Nasal Drug Delivery Technology Market Analysis
- 13 Latin America Nasal Drug Delivery Technology Market Analysis
- 13.1 Key Findings
- 13.2 Latin America Nasal Drug Delivery Technology Market Attractiveness Index
- 13.3 Latin America Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
- 13.4 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
- 13.5 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
- 13.6 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
- 13.7 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
- 13.8 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
- 13.9 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
- 13.10 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
- 13.11 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
- 13.12 Brazil Nasal Drug Delivery Technology Market Analysis
- 13.13 Mexico Nasal Drug Delivery Technology Market Analysis
- 13.14 Argentina Nasal Drug Delivery Technology Market Analysis
- 13.15 Colombia Nasal Drug Delivery Technology Market Analysis
- 13.16 Chile Nasal Drug Delivery Technology Market Analysis
- 13.17 Rest of Latin America Nasal Drug Delivery Technology Market Analysis
- 14 MEA Nasal Drug Delivery Technology Market Analysis
- 14.1 Key Findings
- 14.2 MEA Nasal Drug Delivery Technology Market Attractiveness Index
- 14.3 MEA Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
- 14.4 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
- 14.5 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
- 14.6 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
- 14.7 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
- 14.8 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
- 14.9 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
- 14.10 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
- 14.11 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
- 14.12 GCC Nasal Drug Delivery Technology Market Analysis
- 14.13 South Africa Nasal Drug Delivery Technology Market Analysis
- 14.14 Turkey Nasal Drug Delivery Technology Market Analysis
- 14.15 Egypt Nasal Drug Delivery Technology Market Analysis
- 14.16 Rest of MEA Nasal Drug Delivery Technology Market Analysis
- 15 Company Profiles
- 15.1 Competitive Landscape, 2022
- 15.2 Strategic Outlook
- 15.3 Becton, Dickinson, and Company
- 15.3.1 Company Snapshot
- 15.3.2 Company Overview
- 15.3.3 Financial Analysis
- 15.3.3.1 Net Revenue, 2017-2022
- 15.3.3.2 R&D, 2017-2022
- 15.3.3.3 Regional Market Shares, 2022
- 15.3.3.4 Segment Market Shares, 2022
- 15.3.4 Product Benchmarking
- 15.4 GSK plc
- 15.4.1 Company Snapshot
- 15.4.2 Company Overview
- 15.4.3 Financial Analysis
- 15.4.3.1 Net Revenue, 2017-2022
- 15.4.3.2 R&D, 2017-2022
- 15.4.3.3 Regional Market Shares, 2022
- 15.4.3.4 Business Segment Market Shares, 2022
- 15.4.4 Product Benchmarking
- 15.5 Johnson & Johnson
- 15.5.1 Company Snapshot
- 15.5.2 Company Overview
- 15.5.3 Financial Analysis
- 15.5.3.1 Net Revenue, 2017-2022
- 15.5.3.2 R&D, 2017-2022
- 15.5.3.3 Regional Market Shares, 2022
- 15.5.3.4 Business Segment Market Shares, 2022
- 15.5.4 Product Benchmarking
- 15.5.5 Strategic Outlook
- 15.6 Merck & Co., Inc
- 15.6.1 Company Snapshot
- 15.6.2 Company Overview
- 15.6.3 Financial Analysis
- 15.6.3.1 Net Revenue, 2017-2022
- 15.6.3.2 R&D, 2017-2022
- 15.6.3.3 Regional Market Shares, 2022
- 15.6.3.4 Business Segment Market Shares, 2022
- 15.6.4 Product Benchmarking
- 15.7 Novartis AG
- 15.7.1 Company Snapshot
- 15.7.2 Company Overview
- 15.7.3 Financial Analysis
- 15.7.3.1 Net Revenue, 2017-2022
- 15.7.3.2 R&D, 2017-2022
- 15.7.3.3 Regional Market Shares, 2022
- 15.7.3.4 Business Segment Market Shares, 2022
- 15.7.4 Product Benchmarking
- 15.8 Teva Pharmaceutical Industries Ltd.
- 15.8.1 Company Snapshot
- 15.8.2 Company Overview
- 15.8.3 Financial Analysis
- 15.8.3.1 Net Revenue, 2017-2022
- 15.8.3.2 R&D, 2017-2022
- 15.8.3.3 Regional Market Shares, 2022
- 15.8.3.4 Business Segment Market Shares, 2022
- 15.8.4 Product Benchmarking
- 15.8.5 Strategic Outlook
- 15.9 AptarGroup, Inc
- 15.9.1 Company Snapshot
- 15.9.2 Company Overview
- 15.9.3 Financial Analysis
- 15.9.3.1 Net Revenue, 2017-2022
- 15.9.3.2 R&D, 2017-2022
- 15.9.3.3 Regional Market Shares, 2022
- 15.9.3.4 Business Segment Market Shares, 2022
- 15.9.4 Product Benchmarking
- 15.9.5 Strategic Outlook
- 15.10 AstraZeneca PLC
- 15.10.1 Company Snapshot
- 15.10.2 Company Overview
- 15.10.3 Financial Analysis
- 15.10.3.1 Net Revenue, 2017-2022
- 15.10.3.2 R&D, 2017-2022
- 15.10.3.3 Regional Market Shares, 2022
- 15.10.3.4 Business Segment Market Shares, 2022
- 15.10.4 Product Benchmarking
- 15.10.5 Strategic Outlook
- 15.11 Presspart Verwaltungs GmbH
- 15.11.1 Company Snapshot
- 15.11.2 Company Overview
- 15.11.3 Product Benchmarking
- 15.11.4 Strategic Outlook
- 15.12 Recipharm AB
- 15.12.1 Company Snapshot
- 15.12.2 Company Overview
- 15.12.3 Product Benchmarking
- 15.12.4 Strategic Outlook
- 15.13 Neurelis Inc.
- 15.13.1 Company Snapshot
- 15.13.2 Overview
- 15.13.3 Product Benchmarking
- 15.13.4 Strategic Outlook
- 15.14 PendoPharm Inc.
- 15.14.1 Company Snapshot
- 15.14.2 Company Overview
- 15.14.3 Product Benchmarking
- 15.15 Naveh Pharma Ltd.
- 15.15.1 Company Snapshot
- 15.15.2 Company Overview
- 15.15.3 Product Benchmarking
- 15.16 Dr. Reddy's Laboratories
- 15.16.1 Company Snapshot
- 15.16.2 Company Overview
- 15.16.3 Financial Analysis
- 15.16.3.1 Net Revenue, 2017-2022
- 15.16.3.2 R&D, 2017-2022
- 15.16.3.3 Regional Market Shares, 2022
- 15.16.3.4 Business Segment Market Shares, 2022
- 15.16.4 Product Benchmarking
- 15.17 Pfizer Inc
- 15.17.1 Company Snapshot
- 15.17.2 Company Overview
- 15.17.3 Financial Analysis
- 15.17.3.1 Net Revenue, 2017-2022
- 15.17.3.2 R&D, 2017-2022
- 15.17.3.3 Regional Market Shares, 2022
- 15.17.3.4 Business Segment Market Shares, 2022
- 15.17.4 Product Benchmarking
- 15.17.5 Strategic Outlook
- 15.18 Nemera
- 15.18.1 Company Snapshot
- 15.18.2 Company Overview
- 15.18.3 Product Benchmarking
- 15.18.4 Strategic Outlook
- 15.19 Teleflex Incorporated
- 15.19.1 Company Snapshot
- 15.19.2 Company Overview
- 15.19.3 Product Benchmarking
- 15.20 Optinose US, Inc
- 15.20.1 Company Snapshot
- 15.20.2 Company Overview
- 15.20.3 Product Benchmarking
- 15.21 Flo Nasal Solution
- 15.21.1 Company Snapshot
- 15.21.2 Company Overview
- 15.21.3 Product Benchmarking
- 15.22 Bayer AG
- 15.22.1 Company Snapshot
- 15.22.2 Company Overview
- 15.22.3 Financial Analysis
- 15.22.3.1 Net Revenue, 2017-2022
- 15.22.3.2 R&D, 2017-2022
- 15.22.3.3 Regional Market Shares, 2022
- 15.22.3.4 Business Segment Market Shares, 2022
- 15.22.4 Product Benchmarking
- 16 Conclusion and Recommendations
- 16.1 Concluding Remarks from
- 16.2 Recommendations for Market Players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.